Intratumoral injections of 5-HTP into B16- or MC38-tumor-bearing experimental mice led to the upregulation of inhibitory receptors and simultaneously reduced the production of effector molecules interferon-gamma and tumor necrosis factor in CD8+ TILs [41]. The gene discussed is CD8A; the disease is neoplasm.